Recent Stock Pullback: Procter & Gamble has seen a notable decline in its stock price recently, with a drop of about 13% this year. Discussions on social media highlight this pullback as a potential opportunity for long-term investors, especially those focused on dividends. Many are debating whether the current price reflects a hidden value.
Analyst Updates: Social media chatter also focuses on recent analyst revisions, with some firms lowering price targets while maintaining neutral ratings. Others are more optimistic, pointing to the company’s history of dividend increases and steady revenue growth as reasons for confidence. The mixed signals are fueling lively debates among followers.
Market Sentiment: There’s also talk about political trades involving the stock, with some noting insider transactions as a point of curiosity. While revenue and profitability growth are acknowledged, concerns about market momentum and valuation linger in conversations. The tone remains speculative as investors weigh the risks and rewards.
Note: This discussion summary was generated from an AI condensation of post data.
Procter & Gamble Insider Trading Activity
Procter & Gamble insiders have traded $PG stock on the open market 25 times in the past 6 months. Of those trades, 0 have been purchases and 25 have been sales.
Here’s a breakdown of recent trading of $PG stock by insiders over the last 6 months:
- JON R MOELLER (Chairman, President and CEO) has made 0 purchases and 2 sales selling 51,803 shares for an estimated $8,088,342.
- SHAILESH JEJURIKAR (Chief Operating Officer) has made 0 purchases and 2 sales selling 17,025 shares for an estimated $2,657,488.
- ANDRE SCHULTEN (Chief Financial Officer) has made 0 purchases and 3 sales selling 15,891 shares for an estimated $2,477,831.
- R. ALEXANDRA KEITH (CEO - Beauty) has made 0 purchases and 4 sales selling 13,717 shares for an estimated $2,156,107.
- GARY A COOMBE (CEO - Grooming) has made 0 purchases and 2 sales selling 13,729 shares for an estimated $2,150,411.
- JENNIFER L. DAVIS (CEO - Health Care) has made 0 purchases and 2 sales selling 11,823 shares for an estimated $1,843,177.
- MARC S. PRITCHARD (Chief Brand Officer) sold 9,849 shares for an estimated $1,548,989
- SUNDAR G. RAMAN (CEO-Fabric & Home Care) sold 9,554 shares for an estimated $1,511,050
- SUSAN STREET WHALEY (Chief Legal Officer & Secy) has made 0 purchases and 3 sales selling 9,575 shares for an estimated $1,493,316.
- MA. FATIMA FRANCISCO (CEO - Baby, Fem & Family Care) sold 9,100 shares for an estimated $1,431,191
- BALAJI PURUSHOTHAMAN (Chief Human Resources Officer) has made 0 purchases and 2 sales selling 1,096 shares for an estimated $169,901.
- MATTHEW W. JANZARUK (SVP - Chief Accounting Officer) has made 0 purchases and 2 sales selling 1,044 shares for an estimated $158,608.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Procter & Gamble Revenue
Procter & Gamble had revenues of $22.4B in Q1 2026. This is an increase of 2.99% from the same period in the prior year.
You can track PG financials on Quiver Quantitative's PG stock page.
Procter & Gamble Congressional Stock Trading
Members of Congress have traded $PG stock 19 times in the past 6 months. Of those trades, 8 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $PG stock by members of Congress over the last 6 months:
- REPRESENTATIVE ED CASE sold up to $15,000 on 12/01.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 2 purchases worth up to $30,000 on 11/18, 10/17 and 0 sales.
- REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 11/13, 08/14.
- REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $50,000 on 11/06.
- REPRESENTATIVE RICHARD MCCORMICK purchased up to $15,000 on 11/05.
- REPRESENTATIVE VAL T. HOYLE has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 09/23, 07/02.
- REPRESENTATIVE DAVID TAYLOR has traded it 4 times. They made 4 purchases worth up to $60,000 on 09/22, 08/13, 08/07 and 0 sales.
- REPRESENTATIVE KATHERINE M. CLARK has traded it 2 times. They made 0 purchases and 2 sales worth up to $100,000 on 09/17.
- REPRESENTATIVE TIM MOORE sold up to $15,000 on 09/10.
- REPRESENTATIVE ADAM SMITH sold up to $15,000 on 08/08.
- REPRESENTATIVE RITCHIE TORRES sold up to $15,000 on 07/11.
- REPRESENTATIVE LISA C. MCCLAIN sold up to $15,000 on 07/10.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
Procter & Gamble Hedge Fund Activity
We have seen 1,657 institutional investors add shares of Procter & Gamble stock to their portfolio, and 2,092 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- KINGSTONE CAPITAL PARTNERS TEXAS, LLC removed 76,019,740 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $11,680,433,051
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 15,836,299 shares (+70.3%) to their portfolio in Q3 2025, for an estimated $2,433,247,341
- BLACKROCK, INC. added 6,580,590 shares (+3.8%) to their portfolio in Q3 2025, for an estimated $1,011,107,653
- GQG PARTNERS LLC removed 2,708,435 shares (-56.7%) from their portfolio in Q3 2025, for an estimated $416,151,037
- WELLINGTON MANAGEMENT GROUP LLP removed 2,483,736 shares (-17.9%) from their portfolio in Q3 2025, for an estimated $381,626,036
- AMUNDI added 2,222,560 shares (+26.3%) to their portfolio in Q3 2025, for an estimated $341,496,344
- ALLIANCEBERNSTEIN L.P. removed 2,035,036 shares (-34.6%) from their portfolio in Q3 2025, for an estimated $312,683,281
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Procter & Gamble Analyst Ratings
Wall Street analysts have issued reports on $PG in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Jefferies issued a "Buy" rating on 12/17/2025
- Wells Fargo issued a "Overweight" rating on 09/25/2025
- UBS issued a "Buy" rating on 07/17/2025
To track analyst ratings and price targets for Procter & Gamble, check out Quiver Quantitative's $PG forecast page.
Procter & Gamble Price Targets
Multiple analysts have issued price targets for $PG recently. We have seen 9 analysts offer price targets for $PG in the last 6 months, with a median target of $174.0.
Here are some recent targets:
- Andrea Teixeira from JP Morgan set a target price of $157.0 on 12/18/2025
- Kaumil Gajrawala from Jefferies set a target price of $179.0 on 12/17/2025
- Olivia Tong from Raymond James set a target price of $175.0 on 10/20/2025
- Olivia Tong from B of A Securities set a target price of $174.0 on 10/08/2025
- Peter Grom from UBS set a target price of $176.0 on 10/08/2025
- Lauren Lieberman from Barclays set a target price of $153.0 on 10/01/2025
- Chris Carey from Wells Fargo set a target price of $170.0 on 09/25/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
